Ventolin 1 mg/ml concentrate for solution for intravenous infusion
Authorisation PA1077/049/002 · GlaxoSmithKline (Ireland) Limited
- Licence holder
- GlaxoSmithKline (Ireland) Limited (all products →)
- Active substance
- Salbutamol
- Clinical trials
- 5 clinical trials →
- Dosage form
- Concentrate for solution for infusion
- Route of administration
- Intravenous use
- ATC codes
- R03CC, R03CC02
- First authorised
- 10/11/1975
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Salbutamol: supply and approvals
18 authorised products on the HPRA list contain Salbutamol. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- Salbutamol inhalation products: Shortage resolved, first published 5 Jun 2024
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 17 Nov 2026)
- Germany (BfArM)
- 3 supply notices, e.g. Bronchospray novo (13 Nov 2026 to 22 Jan 2027)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 51 years (since 10 November 1975). The HPRA list marks it as marketed in Ireland.
Other medicines with Salbutamol in Ireland
9 other products on the HPRA list contain Salbutamol, from 5 licence holders; 5 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Salamol CFC-Free Inhaler 100 micrograms pressurised inhalation, suspension | Norton Waterford | National authorisation (PA) | Marketed |
| Salamol Steri-Neb 5 mg/2.5 ml Nebuliser Solution | Teva B.V. | National authorisation (PA) | Marketed |
| Ventolin 500 micrograms/ml solution for injection | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Ventolin Diskus 200 micrograms Inhalation Powder, pre-dispensed | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Ventolin Evohaler 100 micrograms pressurised inhalation, suspension | GlaxoSmithKline (Ireland) Limited | National authorisation (PA) | Marketed |
| Brodilaten 1.25 mg/2.5 ml Nebuliser solution | Noridem Enterprises Limited | National authorisation (PA) | Not marketed |
| Brodilaten 2.5 mg/2.5 ml nebuliser solution | Noridem Enterprises Limited | National authorisation (PA) | Not marketed |
| Brodilaten 5.0 mg/2.5 ml Nebuliser solution | Noridem Enterprises Limited | National authorisation (PA) | Not marketed |
| Zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution | Cipla Europe | National authorisation (PA) | Not marketed |
Other substances in ATC group R03CC
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 1 other active substance shares the group R03CC with this product:
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
GlaxoSmithKline (Ireland) Limited holds 95 products on the HPRA list, with 63 different active substances; 77 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 18 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.